Effect of PNF stretching and chest mobility exercises in Covid-19 survivors

Phase 2/3

Completed

Conditions: Coronavirus as the cause of diseases classified elsewhere, (2) ICD-10 Condition: J984||Other disorders of lung,

Registration Number: CTRI/2021/08/035492

Brief Summary: Recent evidence suggests that the lungs are the organ most affected by COVID-19 with different pathophysiological events. In a study conducted by Elif Hocaoglu,et al ,it was found that the CT-derived measurements of the pectoralis muscle can be useful in predicting disease severity and mortality rate of COVID19 pneumonia in adult patients. Suitable lengthening of soft tissue around the chest wall and respiratory muscles is required for efficiency of contraction force of respiratory muscles and chest movement.

Symptoms are often ignored by patient over a period of time once they are tested negative. Symptom most commonly noticed are fatigue and shortness of breath which may last upto many months. It has also been reported that the individuals ignore the mild symptoms and not focus on cardiorespiratory fitness. Researches have also proved the Chest PNF has been effective in COPD which have similar symptoms as that of COVID. Physiotherapy based rehabilitation program is an essential component for post COVID-19 patients in facilitating maximum functional recovery. As the disease affects lung, the respiratory muscles are also involved. This would further affect the chest expansion and the pulmonary function. PNF stretching for subject appears to be safe and effective in chronic respiratory patients with adaptive shortening and stiffness around the upper limb muscle treatment.

Hence, the purpose of this study is to find the effect of Hold-relax PNF stretching and chest mobility exercises on pulmonary function test such as FEV1, FVC, FEV1/FVC ratio, fatigue and chest expansion for post COVID-19 survivors.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 40

Inclusion Criteria

Post Covid patients with mild and moderate recovery- Asymptomatic Does not need oxygen support on exercise or activity MMRC dyspnea grade <2 Subjects who are independent in mobility Subjects willing to participate.Â Duration : 6-8 months after recovery Baseline values for chest expansion: Upper thoracic: male- 2.6+1.4cm female- 2.2+1.2cm Lower thoracic: male- 2.3+1.1.2cm female- 1.7+1.1cm.

Exclusion Criteria

Any musculoskeletal disorders affecting upper limb.
Any pathological condition affecting muscle, joint and bone Such as rheumatoid arthritis, severe osteoporosis.
Cardiovascular dysfunction (eg, ischemic heart disease, uncontrolled hypertension) Additional conditions restricting chest expansion.
(eg, obesity, severe scoliosis, ankylosing spondylitis) Recent chest or abdominal surgery.
Pathology of spine such as disc protrusion, spondylolisthesis.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary Function-Spirometry	7 sessions/1week. \| pulmonary function will be assesed with spirometry on the first session and after the last session.

Secondary Outcome Measures

Name	Time	Method
Fatigue	VAS for fatigue
Chest Expansion-Inch Tape	It will be assessed before the first session on day1 and after the last session on day7.

Trial Locations

Locations (1): Dr. D. Y. Patil College of Physiotherapy, Dr. D. Y. Patil Vidyapeeth
🇮🇳
Pune, MAHARASHTRA, India
Dr. D. Y. Patil College of Physiotherapy, Dr. D. Y. Patil Vidyapeeth
🇮🇳Pune, MAHARASHTRA, India
Dr Divya Gohil
Principal investigator
7767828290
divya.gohil@dpu.edu.in